Skip to main content

R01: Genetic Origins of Adverse Outcomes in African Americans with Lymphoma

Research Grant
Duke Scholars

Administered By

Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

National Institutes of Health

Start Date

April 18, 2023

End Date

March 31, 2028
 

Administered By

Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

National Institutes of Health

Start Date

April 18, 2023

End Date

March 31, 2028